UnknownNCT02100761

CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
dingshifang
Principal Investigator
Shifang Ding, Ph.D.
Qilu Hospital of Shandong University
Intervention
Voriconazole(drug)
Enrollment
200 enrolled
Eligibility
18-80 years · All sexes
Timeline
20142015

Study locations (1)

Collaborators

Shandong Provincial Hospital · Qianfoshan Hospital · Shandong thorax hospital · Jinan Military General Hospital · Jinan Central Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02100761 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials